Regulatory

What products can we label and market as medical foods? Despite updated FDA draft guidance on medical foods in 2013, the medical foods sector is more confused than ever about what the category means.

As the Safe and Accurate Food Labeling Act makes its way through Congress, ingredient suppliers are left with some crucial questions.

Nowhere does FDA’s letter say the agency plans to change its existing GMP regulations for supplements at this time.

Folic acid and vitamin B12 are two ingredients facing supply challenges, says distributor Green Wave Ingredients.

This latest proposal supplements the agency’s March 2014 proposal to overhaul the Nutrition Facts Label.

Passed by the U.S. House today, the Safe and Accurate Food Labeling Act would make it impossible for states to mandate GMO labeling.

Post NY AG investigation, how has DNA testing actually impacted the dietary supplements industry?

The new guidelines set serving size recommendations and label advisories for melatonin supplements for sleep support.

Three proposed amendments to limit military access to dietary supplements failed to make it to a floor vote in the senate last week.

Conditions include gluten-free ingredients sourcing, cross-contamination controls, and operational management.

“Not having the cGMPs apply to ingredient suppliers definitely creates a gap in supply-chain integrity, says ONHA’s CEO and Executive Director Karen Howard.

NY AG Schneiderman and IN AG Zoeller identified four "major flaws" in FDA's cGMPs for dietary supplements.

SunOpta’s manufacturing facility in Minnesota is the first to be PVP-verified for a non-GMO claim by the USDA.

Two high-profile lawsuits may become the first to judge the constitutionality of GMO and Prop 65 labeling.

Questions include how to prevent cross-contamination and how to comply with FDA’s gluten-free rules.

The senators also criticized the “inconsistent” enforcement actions of the Department of Justice under Lynch’s predecessor, Eric Holder.

Tetrahedron is now seeking broad U.S. commercialization of its unique nature-identical ingredient Ergoneine.

“I personally feel bad for all the Chinese companies that are and have been producing good products,” says USCHPA's Crowther.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

Companies must have a realistic understanding of the timeframes and effort involved.

The first months of 2015 have already offered the agency several possible opportunities to comment or take regulatory action on caffeine.

Companies must have a realistic understanding of the timeframes and effort involved.

The move comes less than a week after FDA enforced against a different stimulant adulterant.

No transparency? Pivotal data in the case building against the dietary supplement industry is still under the NY AG's lock and key.

The New York Attorney General wants better quality assurance for dietary supplements. So does the supplements industry. So how does it get there?